The FDA has approved BridgeBio Pharma's acoramidis for life-threatening heart disorder transthyretin amyloidosis cardiomyopathy (ATTR-CM), setting up a market showdown with its larger rival Pfizer.
Apple has released Safari Technology Preview 241, the latest version of its developer preview web browser. The preview ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results